Advertisement
Original research article| Volume 56, ISSUE 2, P59-65, August 1997

The effects of oral contraceptives on delayed onset muscle soreness following exercise

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Several authors have suggested that estrogen may serve to protect skeletal muscle from exercise-induced damage. The present study examined the effects of regularly ingesting estrogen, in the form of oral contraceptives, on postexercise muscle damage following a bench-stepping regimen. Women currently ingesting oral contraceptives (OC) were compared with eumennorheic controls (CG). All subjects performed a 50-min stepping exercise during the midluteal phase of their menstrual cycle. Muscle damage was evaluated on 2, 3, and 5 days postexercise using several established indirect indicators: perceived soreness, strength and range of motion changes, girth measurements, and creatine kinase (CK) activity. Subjects on OC reported significantly lower quadriceps soreness (p < 0.05) relative to the CG (peak soreness = 4.0 and 7.8, respectively, on a scale of 1–10 where 1 is normal and 10 is very, very sore). These results indicate that oral contraceptive use attenuates soreness following an exhaustive stepping activity but cannot support a relationship between estrogen ingestion and other indices of exercise-induced muscle damage.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Clarkson PM
        • Trembley I
        Exercise-induced muscle damage, repair and adaptation in humans.
        J Appl Physiol. 1988; 65: 1-6
        • Friden J
        • Sjostrom M
        • Ekblom B
        A morphological study of delayed muscle soreness.
        Experientia. 1981; 37: 506-507
        • Clarkson PM
        • Ebbeling CB
        Exercise-induced muscle damage and adaptation.
        Sports Med. 1989; 7: 207-234
        • Bar PR
        • Koot RW
        • Amelink GJ
        Muscle damage revisited: does tamoxifen protect by membrane stabilisation or radical scavenging, rather than via the E2-receptor? (abst).
        Biochem Soc Trans. 1995; 23
        • Van der Meulen JH
        • Kuipers H
        • Drukker J
        Relationship between exercise-induced muscle damage and enzyme release in rats.
        J Appl Physiol. 1991; 71: 999-1004
        • Amelink GJ
        • Koot RW
        • Erich WBM
        • Gijn V
        • Bar PR
        Sex-linked variation in creatinine kinase release and its dependence on oestradiol can be demonstrated in vitro in rat skeletal muscle preparation.
        Acta Physiol Scand. 1990; 138: 115-124
        • Amelink GJ
        • Wal WA
        • Wokke JH
        • van Asbeck BS
        • Bar PR
        Exercise-induced muscle damage in the rat: the effect of vitamin E deficiency.
        Pflügers Arch. 1991; 419: 304-391
        • Bar PR
        • Amelink GJ
        • Oldenburg J
        • Blankenstein M
        Prevention of exercise-induced muscle membrane damage by oestradiol.
        Life Sci. 1988; 42: 2677-2681
        • Dahlberg E
        Characterization of the cytosolic estrogen receptor in rat skeletal muscle.
        Biochem Biophysica Acta. 1982; 717: 65-75
        • Koot R
        • Amelink GJ
        • Blankenstein M
        • Bar PR
        Tamoxifen and oestrogen both protect the rat muscle against physiological damage.
        J Steroid Biochem Molec Biol. 1991; 40: 689-695
        • Jenkins RR
        • Drause D
        • Schofield LS
        Influence of exercise on clearance of oxidant stress products and loosely bound iron.
        Med Sci Sports Exerc. 1993; 25: 213-317
        • Alessio HM
        • Goldfarb AH
        Lipid peroxidation and scavenger enzymes during exercise: adaptive response to training.
        J Appl Physiol. 1988; 64: 1333-1336
        • Ji LL
        Exercise and oxidative stress: role of cellular oxidative systems.
        Exerc Sci Sports Rev. 1995; 23: 135-140
        • Jenkins RR
        Free radical chemistry: relationship to exercise.
        Sports Med. 1988; 5: 156-170
        • Shumate J
        • Brooke M
        • Carroll J
        • Davis J
        Increased serum creatinine kinase after exercise: a sex linked phenomenon.
        Neurology. 1978; 29: 902-904
        • Tiidus PM
        • Ianuzzo CD
        Effects of intensity and duration of muscular exercise on delayed soreness and serum enzyme activities.
        Med Sci Sports Exerc. 1983; 5: 461-465
        • Miles MP
        • Clarkson PM
        • Smith LL
        • Howell JN
        • McCammon MR
        Serum creatinine kinase activity in males and females following two bouts of eccentric exercise (abst).
        Med Sci Sport Exerc. 1994; 26: S168
        • Newham DJ
        • Jones DA
        • Edwards RHT
        Large and delayed plasma creatinine kinase changes after stepping exercise.
        Muscle Nerve. 1983; 6: 36-41
        • Friden J
        • Sjostrom M
        • Ekblom B
        Myofibrillar damage following intense eccentric exercise in man.
        Int J Sports Med. 1983; 4: 170-176
        • Newham DJ
        • McPhail G
        • Mills KR
        • Edwards RHT
        Ultrastructural changes after concentric and eccentric contractions.
        J Neurol Sci. 1983; 61: 109-122
        • Newham DJ
        • Jones DA
        • Tolfree SEJ
        • Edwards RHT
        Skeletal muscle damage: a study of isotope uptake, enzyme efflux and pain after stepping.
        Eur J Appl Physiol. 1986; 55: 106-112
        • Armstrong RB
        • Ogilvie RW
        • Schwane JA
        Eccentric exercise-induced injury to rat skeletal muscle.
        J Appl Physiol: Respir Environ Exerc Physiol. 1983; 54: 80-93
        • Smith LL
        Acute inflammation: the underlying mechanism in delayed onset muscle soreness?.
        Med Sci Sports Exerc. 1991; 23: 542-551
        • Cannon JG
        • Fielding RA
        • Fiatore MA
        • Orencole SF
        • Dinarello CA
        • Evans WJ
        Increases in interleukin-1-beta in human skeletal muscle after exercise.
        Am J Physiol. 1989; 257: R451-R455
        • Colley CM
        • Fleck A
        • Goode AW
        • Muller BR
        • Myers MA
        Early time course of the acute phase protein response in man.
        J Clin Pathol. 1983; 36: 203-207
        • Bomalaski JS
        • Williamson PK
        • Lurier RB
        Prostaglandins and the inflammatory response.
        Clin Lab Med. 1983; 3: 695-710
        • Bansil CK
        • Wilson GD
        • Stone MH
        Role of prostaglandins E and F2α; in exercise-induced delayed muscle soreness.
        Med Sci Sports Exerc. 1985; 17: 276-280
        • Moncada S
        • Ferreira SH
        • Vane JR
        Pain and inflammatory mediators.
        in: Vane JR Ferreira SH Inflammation. Springer-Verlag, New York1978: 588-616
        • Henry PD
        • Bentley KI
        Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.
        J Clin Invest. 1981; 68: 1366-1369
        • Lichtlen PR
        • Hugenholtz PG
        • Rafflenbeul W
        • Hecker H
        • Jost S
        • Deckers JW
        Retardation of angiographic progression of coronary artery disease by nifedipine.
        Lancet. 1990; 335: 1109-1113
        • Hemler ME
        • Lands WEM
        Evidence for a peroxide-initiated free radical mechanism of prostaglandin synthesis.
        J Biol Chem. 1980; 255: 6253-6261
        • Datta S
        • Hurley RJ
        • Naulty JS
        • et al.
        Plasma and cerebrospinal fluid progesterone concentrations in pregnant and nonpregnant women.
        Anest Analag. 1986; 65: 950-954
        • Dawson-Basoa MB
        • Gintzler AR
        17β-Estradiol and progesterone modulate an intrinsic opioid analgesic system.
        Brain Res. 1993; 601: 241-245
        • Martinez-Gomez M
        • Criz Y
        • Salas M
        • Hudson R
        • Pacheco P
        Assessing pain threshold in the rat: changes with estrus and time of day.
        Phys Behav. 1994; 55: 651-667
        • Wehrenberg WB
        • Wardlaw SL
        • Frantz AG
        • Ferin M
        β-Endorphin in hypophyseal portal blood: variations through the menstrual cycle.
        Endocrin. 1982; 111: 879-882
        • Gintzler AR
        Endorphin-mediated increase in pain threshold during pregnancy.
        Science. 1980; 210: 193-195
        • Gintzler AR
        • Bohan MC
        Pain thresholds are elevated during pseudopregnancy.
        Brain Res. 1990; 507: 312-316
        • Ryan SM
        • Maier SF
        The estrous cycle and estrogen modulate stress-induced analgesia.
        Behav Neurosci. 1988; 102: 371-380
        • Wadlaw SL
        • Thoron L
        • Frantz AG
        Effects of sex steroids on brain β-endorphin.
        Brain Res. 1982; 245: 327-331
        • LaBella F
        Opiate receptor activity of 17β-estradiol and related steroids.
        in: Lal H LaBella F Lane J Endocoids. Alan R. Liss, New York1985: 323-328
        • Sander HW
        • Portoghese PS
        • Gintzler AR
        Spinal κ-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a κ-selective antagonist.
        Brain Res. 1988; 474: 343-347
        • Medina VM
        • Dawson-Basoa ME
        • Gintzler AR
        17β-Estradiol and progesterone positively modulate spinal cord dynorphin: relevance to the analgesia of pregnancy.
        Neuroendocrinology. 1993; 58: 310-315
        • Casper RF
        • Bhanot RJ
        • Wilkinson M
        Prolonged elevation of hypothalamic opioid peptide activity in women taking oral contraceptives.
        J Clin Endocrinol. 1984; 58: 582-584